RB1 and retinoblastoma: A platform for initiation of retinoblastoma in a developing human retina in vitro would allow unique freedom to test various temporal settings for the mutagenic events e.g. loss of RB1 function on different levels or gain of a MYCN or OTX2 amplification at different steps in retinal development.